605527151	605527151	CD	B-NP	O
|	|	NN	I-NP	O
HMH	HMH	NN	I-NP	O
|	|	NN	I-NP	O
91358655	91358655	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
8353226	8353226	CD	B-NP	O
|	|	CC	I-NP	O
10/27/2005	10/27/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
ANAPHYLAXIS	ANAPHYLAXIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/2/2005	10/2/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
6/10/2005	6/10/2005	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
IWANEJKO	IWANEJKO	NNP	B-NP	O
,	,	,	O	O
COLLIN	COLLIN	NNP	B-NP	O
M.D.	M.D.	NNP	I-NP	O
ADMISSION	ADMISSION	NNP	I-NP	O
DIAGNOSES	DIAGNOSES	NNP	I-NP	O
:	:	:	O	O
Anaphylaxis	Anaphylaxis	NN	B-NP	O
.	.	.	O	O

ASSOCIATED	ASSOCIATED	VBN	B-NP	O
DIAGNOSES	DIAGNOSES	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Congestive	Congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Hypertension	Hypertension	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Hypothyroidism	Hypothyroidism	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Insulin-dependent	Insulin-dependent	JJ	B-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Polymyalgia	Polymyalgia	NN	B-NP	O
rheumatica	rheumatica	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Diabetic	Diabetic	JJ	B-NP	O
retinopathy	retinopathy	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Urinary	Urinary	JJ	B-NP	O
tract	tract	NN	I-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Adrenal	Adrenal	JJ	B-NP	O
insufficiency	insufficiency	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
86-year-old	86-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
polymyalgia	polymyalgia	NN	B-NP	O
rheumatica	rheumatica	NN	I-NP	O
for	for	IN	B-PP	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
takes	take	VBZ	B-VP	O
steroids	steroid	NNS	B-NP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
developed	develop	VBN	I-VP	O
adrenal	adrenal	JJ	B-NP	O
insufficiency	insufficiency	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
presented	present	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
with	with	IN	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
wheezing	wheezing	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
maculopapular	maculopapular	JJ	I-NP	O
rash	rash	NN	I-NP	O
after	after	IN	B-PP	O
receiving	receive	VBG	B-VP	O
the	the	DT	B-NP	O
pneumovax	pneumovax	NN	I-NP	O
shot	shot	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
received	receive	VBD	B-VP	O
this	this	DT	B-NP	O
shot	shot	NN	I-NP	O
upon	upon	IN	B-PP	O
discharge	discharge	NN	B-NP	O
from	from	IN	B-PP	O
admission	admission	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Baybell	Baybell	NNP	I-NP	O
Lolic	Lolic	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
for	for	IN	B-PP	O
syncope	syncope	NN	B-NP	O
and	and	CC	I-NP	O
dehydration	dehydration	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
treatment	treatment	NN	I-NP	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
IV	IV	CD	B-NP	O
fluids	fluid	NNS	I-NP	O
in	in	IN	B-PP	O
short	short	JJ	B-NP	O
course	course	NN	I-NP	O
and	and	CC	I-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
steroids	steroid	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
steroids	steroid	NNS	B-NP	O
,	,	,	O	O
Benadryl	Benadryl	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Pepcid	Pepcid	NNP	B-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
As	As	IN	B-ADVP	O
above	above	RB	I-ADVP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
BY	BY	NNP	I-NP	O
SYSTEM	SYSTEM	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Immunology	Immunology	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
anaphylactic	anaphylactic	JJ	B-NP	O
reaction	reaction	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Pneumovax	Pneumovax	NN	I-NP	O
shot	shoot	VBD	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
received	receive	VBD	B-VP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
symptoms	symptom	NNS	I-NP	O
resolved	resolve	VBN	B-VP	O
by	by	IN	B-PP	O
hospital	hospital	NN	B-NP	B-protein
day	day	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
1	1	CD	I-NP	I-protein
after	after	IN	B-PP	O
receiving	receive	VBG	B-VP	O
IV	IV	CD	B-NP	O
Benadryl	Benadryl	NN	I-NP	O
around	around	IN	B-PP	O
the	the	DT	B-NP	O
clock	clock	NN	I-NP	O
,	,	,	O	O
Pepcid	Pepcid	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
an	an	DT	B-NP	O
increased	increase	VBN	I-NP	O
dose	dose	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
Hydrocort	Hydrocort	NN	I-NP	O
to	to	TO	B-PP	O
100	100	CD	B-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	B-NP	O
q.	q.	NN	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
steroids	steroid	NNS	I-NP	O
were	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
taper	taper	NN	I-NP	O
and	and	CC	B-PP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
night	night	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
increased	increase	VBN	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
and	and	CC	I-NP	O
oxygen	oxygen	NN	I-NP	O
requirements	requirement	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
oxygen	oxygen	NN	B-NP	O
and	and	CC	O	O
increased	increase	VBN	B-NP	O
steroids	steroid	NNS	I-NP	O
again	again	RB	B-ADVP	O
for	for	IN	B-PP	O
presumed	presumed	JJ	B-NP	O
reexacerbation	reexacerbation	NN	I-NP	O
of	of	IN	B-PP	O
anaphylaxis	anaphylaxis	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
wheezing	wheeze	VBG	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
could	could	MD	B-VP	O
also	also	RB	I-VP	O
be	be	VB	I-VP	O
partly	partly	RB	I-VP	O
explained	explain	VBN	I-VP	O
by	by	IN	B-PP	O
fluid	fluid	NN	B-NP	O
overload	overload	NN	I-NP	O
.	.	.	O	O

By	By	IN	B-PP	O
hospital	hospital	NN	B-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
2	2	CD	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
developed	develop	VBN	I-VP	O
crackles	crackle	NNS	B-NP	O
and	and	CC	O	O
jugular	jugular	JJ	B-NP	O
venous	venous	JJ	I-NP	O
distention	distention	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
diastolic	diastolic	JJ	B-NP	O
heart	heart	NN	I-NP	O
dysfunction	dysfunction	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
diuresis	diuresis	NN	B-NP	O
was	be	VBD	B-VP	O
initiated	initiate	VBN	I-VP	O
.	.	.	O	O

Despite	Despite	IN	B-PP	O
receiving	receive	VBG	B-VP	O
3	3	CD	B-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
IV	IV	NNP	B-NP	O
Lasix	Lasix	NNP	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
flash	flash	NN	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
edema	edema	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
second	second	JJ	I-NP	O
night	night	NN	I-NP	O
of	of	IN	B-PP	O
hospitalization	hospitalization	NN	B-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
stabilized	stabilize	VBN	I-VP	O
with	with	IN	B-PP	O
additional	additional	JJ	B-NP	O
Lasix	Lasix	NN	I-NP	O
and	and	CC	I-NP	O
100	100	CD	I-NP	O
%	%	NN	I-NP	O
nonrebreather	nonrebreather	JJ	I-NP	O
mask	mask	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
nitroglycerin	nitroglycerin	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
200	200	CD	B-NP	O
systolic	systolic	JJ	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
plan	plan	NN	I-NP	O
for	for	IN	B-PP	O
continued	continued	JJ	B-NP	O
diuresis	diuresis	NN	I-NP	O
was	be	VBD	B-VP	O
interrupted	interrupt	VBN	I-VP	O
on	on	IN	B-PP	O
hospital	hospital	NN	B-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
3	3	CD	I-NP	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
became	become	VBD	B-VP	O
hypotensive	hypotensive	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
febrile	febrile	JJ	I-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
UA	UA	NN	I-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
infection	infection	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Levo	Levo	NNP	B-NP	O
for	for	IN	B-PP	O
presumed	presumed	JJ	B-NP	O
urosepsis	urosepsis	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
hospital	hospital	NN	B-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
4	4	CD	I-NP	O
,	,	,	O	O
diuresis	diuresis	NN	B-NP	O
was	be	VBD	B-VP	O
resumed	resume	VBN	I-VP	O
as	as	IN	B-PP	O
her	her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
stabilized	stabilize	VBD	B-VP	O
around	around	IN	B-PP	O
110	110	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
she	she	PRP	B-NP	O
still	still	RB	B-ADVP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
5-6L	5-6L	NN	I-NP	O
oxygen	oxygen	NN	I-NP	O
requirement	requirement	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
reports	report	VBZ	B-VP	O
her	her	PRP$	B-NP	O
dry	dry	JJ	I-NP	O
weight	weight	NN	I-NP	O
is	be	VBZ	B-VP	O
140	140	CD	B-NP	O
to	to	TO	I-NP	O
143	143	CD	I-NP	O
lbs	lb	NNS	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
doctor	doctor	NN	I-NP	O
suspects	suspect	VBZ	B-VP	O
it	it	PRP	B-NP	O
more	more	JJR	B-ADVP	O
like	like	IN	B-PP	O
149	149	CD	B-NP	O
lbs	lb	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
currently	currently	RB	I-VP	O
receiving	receive	VBG	I-VP	O
diuresis	diuresis	NN	B-NP	O
to	to	TO	B-VP	O
wean	wean	VB	I-VP	O
oxygen	oxygen	NN	B-NP	O
requirement	requirement	NN	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
down	down	RB	B-ADVP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
L	L	NN	I-NP	O
per	per	IN	B-PP	O
nasal	nasal	JJ	B-NP	O
cannula	cannula	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
goal	goal	NN	I-NP	O
fluid	fluid	NN	I-NP	O
status	status	NN	I-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-PP	O
negative	negative	JJ	B-NP	O
1	1	CD	I-NP	O
L	L	NN	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
she	she	PRP	B-NP	O
continues	continue	VBZ	B-VP	O
to	to	TO	I-VP	O
receive	receive	VB	I-VP	O
Lasix	Lasix	NN	B-NP	B-protein
IV	IV	CD	I-NP	I-protein
to	to	TO	B-VP	O
meet	meet	VB	I-VP	O
that	that	DT	B-NP	O
goal	goal	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
p.o.	p.o.	FW	B-NP	O
Lasix	Lasix	FW	I-NP	O
30	30	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
some	some	DT	B-NP	O
concern	concern	NN	I-NP	O
about	about	IN	B-PP	O
aspiration	aspiration	NN	B-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
nursing	nursing	NN	I-NP	O
staff	staff	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
immediately	immediately	RB	B-ADVP	O
had	have	VBD	B-VP	O
trouble	trouble	NN	B-NP	O
with	with	IN	B-PP	O
swallowing	swallow	VBG	B-NP	O
liquids	liquid	NNS	I-NP	O
and	and	CC	O	O
Speech	Speech	NN	B-NP	O
and	and	CC	I-NP	O
Swallow	Swallow	NN	I-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
failed	fail	VBD	B-VP	O
the	the	DT	B-NP	O
bedside	bedside	NN	I-NP	O
swallow	swallow	NN	I-NP	O
exam	exam	NN	I-NP	O
and	and	CC	O	O
so	so	RB	B-ADVP	O
a	a	DT	B-NP	O
video	video	NN	I-NP	O
swallow	swallow	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
,	,	,	O	O
which	which	WDT	B-NP	O
actually	actually	RB	B-ADVP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
aspiration	aspiration	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
so	so	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
regular	regular	JJ	I-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

By	By	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
she	she	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
require	require	VB	I-VP	O
any	any	DT	B-NP	O
oxygen	oxygen	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
would	would	MD	B-VP	O
intermittently	intermittently	RB	I-VP	O
desat	desat	VB	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
high	high	JJ	I-NP	O
80s	80	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
would	would	MD	B-VP	O
quickly	quickly	RB	I-VP	O
resolve	resolve	VB	I-VP	O
with	with	IN	B-PP	O
deep	deep	JJ	B-NP	O
breathing	breathing	NN	I-NP	O
or	or	CC	I-NP	O
chest	chest	NN	I-NP	O
PT	PT	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Endocrinology	Endocrinology	NNP	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
PMR	PMR	NN	B-NP	B-protein
and	and	CC	O	O
adrenal	adrenal	JJ	B-NP	O
insufficiency	insufficiency	NN	I-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
30	30	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
Hydrocort	Hydrocort	NN	B-NP	O
daily	daily	RB	B-ADVP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
May	May	NNP	I-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
urosepsis	urosepsis	NN	B-NP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
back	back	RB	B-ADVP	O
on	on	IN	B-PP	O
stress	stress	NN	B-NP	O
dose	dose	NN	I-NP	O
steroids	steroid	NNS	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
then	then	RB	I-VP	O
tapered	taper	VBN	I-VP	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
dose	dose	NN	I-NP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
rest	rest	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
diabetes	diabetes	NN	B-NP	B-protein
type	type	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
requiring	require	VBG	I-NP	I-protein
insulin	insulin	NN	I-NP	I-protein
inhouse	inhouse	NN	I-NP	O
or	or	CC	O	O
oral	oral	JJ	B-NP	O
agents	agent	NNS	I-NP	O
.	.	.	O	O

Oral	Oral	JJ	B-NP	O
agents	agent	NNS	I-NP	O
were	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
and	and	CC	O	O
insulin	insulin	NN	B-NP	B-protein
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
for	for	IN	B-PP	O
glucose	glucose	NN	B-NP	O
control	control	NN	I-NP	O
,	,	,	O	O
NPH	NPH	NN	B-NP	B-protein
30	30	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
and	and	CC	O	O
10	10	CD	B-NP	O
units	unit	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
evening	evening	NN	I-NP	O
seemed	seem	VBD	B-VP	O
to	to	TO	I-VP	O
control	control	VB	I-VP	O
the	the	DT	B-NP	O
a.m.	a.m.	NN	I-NP	O
and	and	CC	I-NP	O
p.m.	p.m.	NN	I-NP	O
sugars	sugar	NNS	I-NP	O
pretty	pretty	RB	B-ADVP	O
well	well	RB	I-ADVP	O
.	.	.	O	O

Regular	Regular	JJ	B-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
was	be	VBD	B-VP	O
added	add	VBN	I-VP	O
6	6	CD	B-NP	O
units	unit	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
with	with	IN	B-PP	O
breakfast	breakfast	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
NPH	NPH	NN	I-NP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
p.m.	p.m.	NN	I-NP	O
blood	blood	NN	I-NP	O
sugar	sugar	NN	I-NP	O
control	control	NN	I-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
the	the	DT	B-NP	O
highest	high	JJS	I-NP	O
blood	blood	NN	I-NP	O
sugar	sugar	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

Obviously	Obviously	RB	B-ADVP	O
,	,	,	O	O
this	this	DT	B-NP	O
needs	need	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
monitored	monitor	VBN	I-VP	O
and	and	CC	I-VP	O
adjusted	adjust	VBN	I-VP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
the	the	DT	B-NP	O
medicine	medicine	NN	I-NP	O
staff	staff	NN	I-NP	O
is	be	VBZ	B-VP	O
going	go	VBG	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
following	follow	VBG	I-VP	O
her	her	PRP	B-NP	O
as	as	IN	B-PP	O
to	to	TO	B-PP	O
whether	whether	IN	B-SBAR	O
she	she	PRP	B-NP	O
should	should	MD	B-VP	O
resume	resume	VB	I-VP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
agents	agent	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
does	do	VBZ	B-VP	O
on	on	IN	B-PP	O
occasion	occasion	NN	B-NP	O
drop	drop	VB	B-VP	O
her	her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
sugar	sugar	NN	I-NP	O
to	to	TO	B-PP	O
50	50	CD	B-NP	O
or	or	CC	I-NP	O
60	60	CD	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
usually	usually	RB	B-ADVP	O
asymptomatic	asymptomatic	JJ	B-ADJP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
Her	Her	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
creatinine	creatinine	NN	I-NP	O
was	be	VBD	B-VP	O
1.0	1.0	CD	B-NP	O
.	.	.	O	O

Both	Both	DT	O	O
her	her	PRP$	B-NP	O
BUN	BUN	NN	I-NP	B-protein
and	and	CC	I-NP	O
creatinine	creatinine	NN	I-NP	O
were	be	VBD	B-VP	O
elevated	elevate	VBN	I-VP	O
with	with	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
needs	need	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
monitored	monitor	VBN	I-VP	O
closely	closely	RB	B-ADVP	O
and	and	CC	O	O
medications	medication	NNS	B-NP	O
need	need	VBP	B-VP	O
to	to	TO	I-VP	O
renally	renally	RB	I-VP	O
dosed	dose	VBN	I-VP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Infectious	Infectious	JJ	B-NP	O
Disease	Disease	NN	I-NP	O
:	:	:	O	O
Her	Her	PRP$	B-NP	O
urine	urine	NN	I-NP	O
was	be	VBD	B-VP	O
positive	positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
greater	great	JJR	B-NP	O
than	than	IN	I-NP	O
100	100	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
group	group	NN	I-NP	O
B	B	NN	I-NP	O
hemolytic	hemolytic	JJ	I-NP	O
Streptococci	Streptococci	NNS	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
started	start	VBN	I-VP	O
with	with	IN	B-PP	O
Levaquin	Levaquin	NN	B-NP	B-protein
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
switched	switch	VBN	I-VP	O
to	to	TO	B-PP	O
penicillin	penicillin	NN	B-NP	B-protein
on	on	IN	B-PP	O
January	January	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
,	,	,	O	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
gram-positive	gram-positive	JJ	I-NP	O
organism	organism	NN	I-NP	O
was	be	VBD	B-VP	O
discovered	discover	VBN	I-VP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
switched	switch	VBN	I-VP	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
Levaquin	Levaquin	NNP	B-NP	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
sensitivities	sensitivity	NNS	I-NP	O
came	come	VBD	B-VP	O
back	back	RB	B-ADVP	O
,	,	,	O	O
and	and	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
sensitive	sensitive	JJ	B-ADJP	O
to	to	TO	B-PP	O
Levaquin	Levaquin	NNP	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
Levaquin	Levaquin	NNP	I-NP	O
is	be	VBZ	B-VP	O
ideal	ideal	JJ	B-ADJP	O
because	because	IN	B-SBAR	O
her	her	PRP$	B-NP	O
coughing	coughing	NN	I-NP	O
could	could	MD	B-VP	O
also	also	RB	I-VP	O
represent	represent	VB	I-VP	O
bronchitis	bronchitis	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
complained	complain	VBN	I-VP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
cough	cough	NN	I-NP	O
since	since	IN	B-PP	O
weeks	week	NNS	B-NP	O
before	before	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
now	now	RB	I-VP	O
resolving	resolve	VBG	I-VP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Disposition	Disposition	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
feel	feel	VB	I-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
can	can	MD	B-VP	O
care	care	VB	I-VP	O
for	for	IN	B-PP	O
herself	herself	PRP	B-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
and	and	CC	I-NP	O
screening	screening	NN	I-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
to	to	TO	B-PP	O
Er	Er	NNP	B-NP	B-protein
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
,	,	,	O	O
and	and	CC	O	O
that	that	DT	B-NP	O
was	be	VBD	B-VP	O
accepted	accept	VBN	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
acute	acute	JJ	I-NP	O
care	care	NN	I-NP	O
center	center	NN	I-NP	O
for	for	IN	B-PP	O
Saturday	Saturday	NNP	B-NP	O
,	,	,	O	O
March	March	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
INSTRUCTIONS	INSTRUCTIONS	NNS	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
just	just	RB	B-ADVP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
primary	primary	JJ	B-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
should	should	MD	B-VP	O
also	also	RB	I-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Wann	Wann	NNP	I-NP	O
from	from	IN	B-PP	O
Pulmonary	Pulmonary	NNP	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
Reddis	Reddis	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
University	University	NNP	I-NP	O
Of	Of	IN	B-PP	O
An	An	DT	B-NP	O
appointment	appointment	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
made	make	VBN	I-VP	O
for	for	IN	B-PP	O
her	her	PRP	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
should	should	MD	B-VP	O
return	return	VB	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
if	if	IN	B-SBAR	O
she	she	PRP	B-NP	O
experiences	experience	VBZ	B-VP	O
chest	ch	JJS	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
further	further	JJ	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
severe	severe	JJ	B-NP	O
sweating	sweating	NN	I-NP	O
,	,	,	O	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
vomiting	vomit	VBG	B-VP	O
,	,	,	O	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
or	or	CC	O	O
other	other	JJ	B-NP	O
concerns	concern	NNS	I-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
glucose	glucose	NN	B-NP	B-protein
116	116	CD	I-NP	I-protein
,	,	,	O	O
BUN	BUN	NN	B-NP	B-DNA
30	30	CD	I-NP	I-DNA
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
1.3	1.3	CD	I-NP	O
,	,	,	O	O
sodium	sodium	NN	B-NP	O
139	139	CD	I-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
3.4	3.4	CD	I-NP	O
;	;	:	O	O
please	please	NN	B-NP	O
make	make	VBP	B-VP	O
a	a	DT	B-NP	O
note	note	NN	I-NP	O
that	that	IN	B-NP	O
her	her	PRP$	B-NP	O
potassium	potassium	NN	I-NP	O
requires	require	VBZ	B-VP	O
repletion	repletion	NN	B-NP	O
and	and	CC	O	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
monitored	monitor	VBN	I-VP	O
;	;	:	O	O
chloride	chloride	NN	B-NP	O
93	93	CD	I-NP	O
,	,	,	O	O
CO2	CO2	NN	B-NP	O
33	33	CD	I-NP	O
,	,	,	O	O
CK	CK	NN	B-NP	B-protein
34	34	CD	I-NP	I-protein
,	,	,	O	O
calcium	calcium	NN	B-NP	O
8.7	8.7	CD	I-NP	O
,	,	,	O	O
magnesium	magnesium	NN	B-NP	O
1.8	1.8	CD	I-NP	O
,	,	,	O	O
troponin	troponin	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
assay	assay	NN	B-NP	O
.	.	.	O	O

White	White	JJ	B-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
is	be	VBZ	B-VP	O
7.04	7.04	CD	B-NP	O
,	,	,	O	O
hemoglobin	hemoglobin	NN	B-NP	B-protein
10.6	10.6	CD	I-NP	I-protein
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
32.8	32.8	CD	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
platelet	platelet	NN	B-NP	B-protein
274	274	CD	I-NP	I-protein
,	,	,	I-NP	O
000	000	CD	I-NP	O
.	.	.	O	O

Urinalysis	Urinalysis	NN	B-NP	O
,	,	,	O	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
100	100	CD	B-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
with	with	IN	B-PP	O
4	4	CD	B-NP	O
+	+	SYM	I-NP	O
beta-hemolytic	beta-hemolytic	JJ	I-NP	O
Streptococcus	Streptococcus	NNP	I-NP	O
group	group	NN	I-NP	O
B	B	NN	I-NP	O
,	,	,	O	O
sensitive	sensitive	JJ	B-ADJP	O
to	to	TO	B-PP	O
penicillin	penicillin	NN	B-NP	O
and	and	CC	I-NP	O
Cipro	Cipro	NN	I-NP	O
;	;	:	O	O
with	with	IN	B-PP	O
Cipro	Cipro	NN	B-NP	O
being	be	VBG	B-VP	O
a	a	DT	B-NP	O
better	good	JJR	I-NP	O
choice	choice	NN	I-NP	O
,	,	,	O	O
i.e.	i.e.	FW	B-NP	O
,	,	,	O	O
levofloxacin	levofloxacin	NN	B-NP	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
her	her	PRP$	B-NP	O
bronchitis	bronchitis	NN	I-NP	O
.	.	.	O	O

CONDITION	CONDITION	NNP	B-NP	O
UPON	UPON	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
:	:	:	O	O
Stable	Stable	NNP	B-NP	O
.	.	.	O	O

See	See	VB	B-VP	O
radiologic	radiologic	JJ	B-NP	O
data	datum	NNS	I-NP	O
.	.	.	O	O

Swallowing	Swallow	VBG	B-VP	O
study	study	NN	B-NP	O
on	on	IN	B-PP	O
July	July	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
,	,	,	O	O
showed	show	VBD	B-VP	O
normal	normal	JJ	B-NP	O
video	video	NN	I-NP	O
swallow	swallow	NN	I-NP	O
.	.	.	O	O

Portable	Portable	JJ	B-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
on	on	IN	B-PP	O
October	October	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
,	,	,	O	O
showed	show	VBD	B-VP	O
new	new	JJ	B-NP	O
bilateral	bilateral	JJ	I-NP	O
perihilar	perihilar	JJ	I-NP	O
opacification	opacification	NN	I-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

Minimal	Minimal	JJ	B-NP	O
left-sided	left-sided	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
is	be	VBZ	B-VP	O
present	present	JJ	B-ADJP	O
and	and	CC	O	O
there	there	EX	B-NP	O
are	be	VBP	B-VP	O
no	no	DT	B-NP	O
pneumothoraces	pneumothorace	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
heart	heart	NN	I-NP	O
is	be	VBZ	B-VP	O
normal	normal	JJ	B-ADJP	O
in	in	IN	B-PP	O
size	size	NN	B-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNP	B-NP	O
UPON	UPON	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
:	:	:	O	O
Tylenol	Tylenol	NN	B-NP	O
650	650	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
4h	4h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	JJ	B-NP	O
headache	headache	NN	I-NP	O
;	;	:	O	O
aspirin	aspirin	NN	B-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
daily	daily	RB	I-ADVP	O
;	;	:	O	O
albuterol	albuterol	NN	B-NP	O
nebulizer	nebulizer	NN	I-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
q.	q.	NN	I-NP	O
4h	4h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
or	or	CC	I-NP	O
wheezing	wheezing	NN	I-NP	O
,	,	,	O	O
of	of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
this	this	DT	B-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
usual	usual	JJ	I-NP	O
medication	medication	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
asthma	asthma	NN	B-NP	O
or	or	CC	I-NP	O
COPD	COPD	NN	I-NP	O
;	;	:	O	O
Dulcolax	Dulcolax	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
daily	daily	RB	I-ADVP	O
;	;	:	O	O
citrate	citrate	NN	B-NP	O
of	of	IN	B-PP	O
magnesia	magnesia	NN	B-NP	O
150	150	CD	I-NP	O
mL	mL	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.	q.	NN	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	JJ	B-NP	O
constipation	constipation	NN	I-NP	O
;	;	:	O	O
Benadryl	Benadryl	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
q.	q.	NN	I-NP	O
8h	8h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-LST	O
wheezing	wheeze	VBG	B-VP	O
or	or	CC	I-VP	O
itching	itch	VBG	I-VP	O
;	;	:	O	O
Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
;	;	:	O	O
Lasix	Lasix	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
;	;	:	O	O
Robitussin	Robitussin	NNP	B-NP	O
10	10	CD	I-NP	O
mL	mL	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.	q.	NN	I-NP	O
4h	4h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	JJ	B-NP	O
cough	cough	NN	I-NP	O
;	;	:	O	O
hydrocortisone	hydrocortisone	NN	B-NP	O
30	30	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
daily	daily	RB	I-ADVP	O
;	;	:	O	O
insulin	insulin	NN	B-NP	B-protein
NPH	NPH	NN	I-NP	I-protein
30	30	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
subcutaneously	subcutaneously	RB	B-ADVP	O
q.a.m.	q.a.m.	RB	I-ADVP	O
;	;	:	O	O
insulin	insulin	NN	B-NP	B-protein
NPH	NPH	NN	I-NP	I-protein
Humulin	Humulin	NN	I-NP	I-protein
10	10	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
subcutaneously	subcutaneously	RB	B-ADVP	O
q.p.m.	q.p.m.	RB	I-ADVP	O
,	,	,	O	O
Insulin	Insulin	NNP	B-NP	B-protein
Regular	Regular	NNP	I-NP	I-protein
Humulin	Humulin	NNP	I-NP	I-protein
6	6	CD	I-NP	I-protein
units	unit	NNS	I-NP	I-protein
subcutaneously	subcutaneously	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
with	with	IN	B-PP	O
breakfast	breakfast	NN	B-NP	O
;	;	:	O	O
acidophilus	acidophilus	NN	B-NP	O
4	4	CD	B-NP	O
tablets	tablet	NNS	I-NP	O
p.o.	p.o.	FW	I-NP	O
t.i.d.	t.i.d.	FW	I-NP	O
;	;	:	O	O
lactulose	lactulose	NN	B-NP	O
30	30	CD	I-NP	O
mL	mL	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
q.i.d.	q.i.d.	FW	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
constipation	constipation	NN	I-NP	O
;	;	:	O	O
Synthroid	Synthroid	JJ	B-NP	O
88	88	CD	I-NP	O
mcg	mcg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
;	;	:	O	O
Senna	Senna	NNP	B-NP	O
tablet	tablet	NN	I-NP	O
2	2	CD	B-NP	O
tablets	tablet	NNS	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
;	;	:	O	O
multivitamin	multivitamin	NN	B-NP	O
1	1	CD	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
;	;	:	O	O
Norvasc	Norvasc	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
hold	hold	VBP	B-VP	O
if	if	IN	B-SBAR	O
systolic	systolic	JJ	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
120	120	CD	B-NP	O
;	;	:	O	O
Compazine	Compazine	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
to	to	TO	B-PP	O
10	10	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	JJ	B-NP	O
nausea	nausea	NN	I-NP	O
;	;	:	O	O
Lovenox	Lovenox	NNP	B-NP	O
40	40	CD	B-NP	O
mg	mg	NN	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
;	;	:	O	O
potassium	potassium	NN	B-NP	O
20	20	CD	I-NP	O
mEq	mEq	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
please	please	VB	B-INTJ	O
note	note	VB	B-VP	O
the	the	DT	B-NP	O
potassium	potassium	NN	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
monitored	monitor	VBN	I-VP	O
and	and	CC	O	O
potassium	potassium	NN	B-NP	O
repleted	replete	VBN	B-VP	O
as	as	IN	B-PP	O
necessary	necessary	JJ	B-ADJP	O
;	;	:	O	O
levofloxacin	levofloxacin	NN	B-NP	O
250	250	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
24h	24h	NN	I-NP	O
.	.	.	O	O

12	12	CD	B-NP	O
more	more	RBR	I-NP	O
total	total	JJ	I-NP	O
doses	dose	NNS	I-NP	O
;	;	:	O	O
Nexium	Nexium	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
;	;	:	O	O
DuoNeb	DuoNeb	NNP	B-NP	O
3/0	3/0	CD	B-NP	O
.5	.5	CD	I-NP	O
mg	mg	NN	I-NP	O
nebulizers	nebulizer	NNS	I-NP	O
q.	q.	VBP	B-VP	O
6h	6h	CD	B-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-LST	O
,	,	,	O	O
please	please	VB	B-VP	O
note	note	NN	B-NP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
a	a	DT	B-NP	O
home	home	NN	I-NP	O
medication	medication	NN	I-NP	O
;	;	:	O	O
Lumigan	Lumigan	NNP	B-NP	O
OU	OU	NNP	I-NP	O
q.d.	q.d.	NN	I-NP	O
;	;	:	O	O
NovoLog	NovoLog	NN	B-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
a.c.	a.c.	RB	I-ADVP	O
and	and	CC	I-ADVP	O
h.s.	h.s.	RB	I-ADVP	O
;	;	:	O	O
Maalox	Maalox	NNP	B-NP	O
p.r.n.	p.r.n.	FW	I-NP	O
ALLERGIES	ALLERGIES	NNPS	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
allergic	allergic	JJ	B-ADJP	O
to	to	TO	B-PP	O
sulfa	sulfa	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
causes	cause	VBZ	B-VP	O
a	a	DT	B-NP	O
rash	rash	NN	I-NP	O
;	;	:	O	O
azathioprine	azathioprine	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
causes	cause	VBZ	B-VP	O
fever	fever	NN	B-NP	O
;	;	:	O	O
sertraline	sertraline	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
causes	cause	VBZ	B-VP	O
nausea	nausea	NN	B-NP	O
;	;	:	O	O
Reglan	Reglan	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
causes	cause	VBZ	B-VP	O
angioedema	angioedema	NN	B-NP	O
;	;	:	O	O
also	also	RB	B-ADVP	O
the	the	DT	B-NP	O
pneumococcal	pneumococcal	JJ	I-NP	O
vaccine	vaccine	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
causes	cause	VBZ	B-VP	O
anaphylaxis	anaphylaxis	NN	B-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
8-9000706	8-9000706	CD	B-NP	O
SSSten	SSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
CRUNKILTON	CRUNKILTON	NNP	B-NP	O
,	,	,	O	O
BRADLY	BRADLY	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
CARASQUILLO	CARASQUILLO	NNP	B-NP	O
,	,	,	O	O
MOHAMMED	MOHAMMED	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
3128477	3128477	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
4/13/05	4/13/05	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
4/13/05	4/13/05	CD	B-NP	O

